These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14702004)

  • 1. Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease.
    Grossman H
    CNS Spectr; 2003 Nov; 8(11):815-23. PubMed ID: 14702004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort.
    Chambers A; Bury JJ; Minett T; Richardson CD; Brayne C; Ince PG; Shaw PJ; Garwood CJ; Heath PR; Simpson JE; Matthews FE; Wharton SB
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):950-958. PubMed ID: 32766675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.
    Beeri MS; Silverman JM; Davis KL; Marin D; Grossman HZ; Schmeidler J; Purohit DP; Perl DP; Davidson M; Mohs RC; Haroutunian V
    J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):471-5. PubMed ID: 15933386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
    Muramori F; Kobayashi K; Nakamura I
    Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians.
    Giannakopoulos P; Hof PR; Vallet PG; Giannakopoulos AS; Charnay Y; Bouras C
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):577-92. PubMed ID: 8588057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is there sugar in the Alzheimer's disease?].
    Frey J
    Ann Biol Clin (Paris); 2001; 59(3):253-7. PubMed ID: 11397672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
    Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
    Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between Alzheimer's disease and vascular dementia: implications for treatment.
    Kalaria RN
    Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein alpha-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer's disease neurofibrillary and amyloid pathologies.
    García-Jiménez A; Fastbom J; Ohm TG; Cowburn RF
    Neuroreport; 2003 Aug; 14(11):1523-7. PubMed ID: 12960778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of characterizing normal brain aging in relation to Alzheimer's disease.
    Morris JC
    Neurobiol Aging; 1997; 18(4):388-9; discussion 389-92. PubMed ID: 9330969
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's disease as a disconnection syndrome?
    Delbeuck X; Van der Linden M; Collette F
    Neuropsychol Rev; 2003 Jun; 13(2):79-92. PubMed ID: 12887040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in Alzheimer's disease hippocampus: a topographical study.
    Cruz-Sánchez FF; Gironès X; Ortega A; Alameda F; Lafuente JV
    J Neurol Sci; 2010 Dec; 299(1-2):163-7. PubMed ID: 20863531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease.
    Hof PR; Perl DP; Loerzel AJ; Morrison JH
    Brain Res; 1991 Nov; 564(2):306-13. PubMed ID: 1810629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
    Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
    Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.